• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis.

作者信息

Yao Lan-Qing, Gong Jin-Bo, Cai Lei, Gu Li-Hui, Liang Ying-Jian, Guo Hong-Wei, Lin Kong-Ying, Li Zi-Qiang, Zheng Qi-Xuan, Zhou Ya-Hao, Chen Ting-Hao, Chen Zhong, Wang Hong, Liu Han, Wu Han, Pawlik Timothy M, Shen Feng, Lai Eric Ch, Yang Tian

机构信息

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200433, China.

Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2025 Jun;24(3):261-268. doi: 10.1016/j.hbpd.2025.03.003. Epub 2025 Mar 18.

DOI:10.1016/j.hbpd.2025.03.003
PMID:40148147
Abstract

BACKGROUND

Despite advances in surgical treatment, high recurrence after surgery remains a challenge for patients with hepatocellular carcinoma (HCC). This study aimed to investigate the association between compliance to regular follow-up and long-term oncological outcomes among patients undergoing curative resection for HCC.

METHODS

This multicenter study included patients who underwent curative resection for early-stage HCC between January 2012 and December 2021 at 12 liver surgery centers. Patients were stratified into a regular follow-up group (follow-up every 2-3 months for the first 2 years and every 3-6 months thereafter) and an irregular/no follow-up group. Overall survival (OS), time to recurrence (TTR), and post-recurrence survival (PRS) were compared between the two groups.

RESULTS

Among 1544 patients, 786 (50.9%) underwent regular follow-up during postoperative follow-up. The regular follow-up group had better OS (median: 113.4 vs. 94.5 months, P = 0.010) and PRS (median: 37.9 vs. 16.3 months, P < 0.001) than the irregular/no follow-up group, although TTR was comparable (median: 61.4 vs. 66.2 months, P = 0.161). Furthermore, patients in the regular follow-up group had a lower incidence of tumor beyond the Milan criteria at recurrence (41.6% vs. 50.4%, P = 0.013) and were more likely to receive curative treatments for recurrence (56.1% vs. 49.3%, P = 0.061). On multivariate analysis, compliance to regular follow-up was an independent factor associated with better OS [hazard ratio (HR) = 0.777, 95% confidence interval (CI): 0.663-0.910, P = 0.002] and PRS (HR = 0.523, 95% CI: 0.428-0.638, P < 0.001).

CONCLUSIONS

Compliance to regular follow-up improved OS and PRS after curative resection for HCC, highlighting the importance of postoperative regular follow-up for early detection of recurrence and timely intervention.

摘要

相似文献

1
Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis.
Hepatobiliary Pancreat Dis Int. 2025 Jun;24(3):261-268. doi: 10.1016/j.hbpd.2025.03.003. Epub 2025 Mar 18.
2
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.
3
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
4
Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma.时间到介入失败作为肝癌切除术后生存结果的新替代指标。
J Gastrointest Surg. 2020 Jan;24(1):50-57. doi: 10.1007/s11605-019-04277-y. Epub 2019 Jun 12.
5
Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.用于术前评估接受根治性切除的巴塞罗那临床肝癌分期A1期以上肝细胞癌患者长期生存情况的列线图。
Oncotarget. 2016 Sep 20;7(38):61378-61389. doi: 10.18632/oncotarget.11358.
6
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study.肝癌切除术后长间隔与短间隔随访的比较:一项回顾性队列研究。
Cancer Commun (Lond). 2018 May 21;38(1):26. doi: 10.1186/s40880-018-0296-x.
7
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.他汀类药物的使用与 BCLC 分期 0-A 期肝癌根治性切除术后复发风险降低相关。
BMC Cancer. 2021 Jan 15;21(1):70. doi: 10.1186/s12885-021-07796-7.
8
Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-Analysis.老年肝细胞癌患者手术切除后的特征与结局:系统评价与Meta分析
Dig Dis. 2025;43(2):206-214. doi: 10.1159/000530101. Epub 2023 Mar 13.
9
Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.预测原发性根治性治疗后早期肝细胞癌长期预后的因素:手术或非手术方法的作用。
BMC Cancer. 2021 Mar 8;21(1):250. doi: 10.1186/s12885-021-07948-9.
10
Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.肝细胞癌自发破裂出血的治疗和预后研究:建议在 BCLC 分期系统中增加 A1 期。
Cancer Med. 2024 May;13(10):e6952. doi: 10.1002/cam4.6952.

引用本文的文献

1
Development and Validation of an Individualized Prediction Model for Postoperative Late Recurrence After Hepatectomy for Hepatocellular Carcinoma (POLAR-HCC): A Multicenter Study.肝细胞癌肝切除术后晚期复发个体化预测模型(POLAR-HCC)的开发与验证:一项多中心研究
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18213-9.